Kopran Ltd.

₹188.07

-3.6 (-1.9%)

KOPRAN Share Price

Pharmaceuticals & Biotechnology

As on July 30, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 905 Cr

P/E Ratio35.29

Dividend Yield0.16 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	195.8	Bearish
10-DMA	198.89	Bearish
20-DMA	197.82	Bearish
50-DMA	191.18	Bearish
100-DMA	166.31	Bullish
200-DMA	155.24	Bullish

Historical Performance

1 Year

13.5%

3 Years

0.9%

5 Years

-21.5%

10 Years

257.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	6,814	6,296	6,146	5,510	4,775
Total Expenditure	6,195	5,567	5,402	4,992	3,903
Other Income	3	40	147	31	108
Operating Profit	623	769	890	549	980
Interest	105	93	86	61	51
Depreciation	175	156	129	127	111
Profit Before Tax	344	519	675	361	818
Consolidated Net Profit	257	386	510	272	610
Adjusted EPS	5	8	11	6	13

Compounded Sales Growth

10 Years:18.1

5 Years:6.7

3 Years:4.3

TTM:1.6

Compounded Profit Growth

10 Years:19.1

5 Years:-16

3 Years:-1.1

TTM:-7.8

Stock Price CAGR

10 Years:13.6

5 Years:-4.7

3 Years:-1.8

TTM:16.7

Return on Equity

10 Years:4.6

5 Years:12.7

3 Years:10.6

last year:5.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	483	483	482	482	482
Total Reserves	4,806	4,684	4,420	3,910	3,780
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	319	367	335	335	331
Other Current Liabilities	474	389	228	328	314
Short Term Borrowings	1,365	1,291	810	555	537
Total Liabilities	9,084	8,440	7,432	6,497	6,109
Capital Work in Progress	23	994	777	557	275
Long Term Loans & Advances	126	110	91	143	82
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	839	945	827	875	756
Total Current Assets	5,232	5,097	4,540	3,991	4,149
Total Assets	9,084	8,440	7,432	6,497	6,109
Adjusted Book Value	110	107	102	91	88

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 35.29, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -1.8%, indicating poor shareholder returns.
The stock carries a high beta of 1.5, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹623 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹6814 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1167339.1

No. of Shares: 6207 (Approx)

Performance:16.7%

167339.1

NIFTY Performance: -1.8%

1 day Top Gainers